292 TAB 30 MG — DIN 00219843
CODEINE PHOSPHATE : 30 MG CAFFEINE CITRATE : 30 MG ACETYLSALICYLIC ACID : 375 MG · MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is 292 TAB?
292 TAB 30 MG contains CODEINE PHOSPHATE : 30 MG CAFFEINE CITRATE : 30 MG ACETYLSALICYLIC ACID : 375 MG. It is listed in the Health Canada Drug Product Database under DIN 00219843, held by MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1998. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Codeine And Acetylsalicylic Acid cost around the world?
Codeine And Acetylsalicylic Acid is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Hungary publishes a producer price (ex-factory); Morocco publishes a PPV (public price). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 31 | 42 | ZAR███.██ |
| Morocco | PPV (public price) | 6 | 6 | MAD███.██ |
| United Kingdom | hospital | 5 | 5 | GBP███.██ |
| United States | acquisition | 3 | 5 | USD███.██ |
| Australia | ex-manufacturer | 1 | 4 | AUD███.██ |
| Hungary | producer price (ex-factory) | 2 | 2 | HUF███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
65 pack listings across 49 brand entries and 7 price bases, refreshed 08 Sep 2026. Ranges span every Codeine And Acetylsalicylic Acid pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Codeine And Acetylsalicylic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
17 holders have a Canadian DIN containing Codeine And Acetylsalicylic Acid, across 26 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PHARMASCIENCE INC | 4 | 0 | A.C.& C TABLETS, AC AND C TAB 1/8GR, AC&C TABLETS, C-2 BUFFERED WITH CODEINE | No marketed DIN |
| D.C. LABS LIMITED | 2 | 0 | A & C TABLETS WITH CODEINE 15MG, A & C TABLETS WITH CODEINE 30MG | No marketed DIN |
| LABORATOIRES CONFAB INC | 2 | 0 | A.C. & C. 8 MG, ASA-CAFFEINE-CODEINE | No marketed DIN |
| MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | 2 | 0 | 282 TAB, 292 TAB | No marketed DIN |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 2 | 0 | 282 TABLETS, 292 TABLETS | No marketed DIN |
| ROUGIER PHARMA DIVISION OF RATIOPHARM INC | 2 | 0 | CORYPHEN 325 CODEINE 30 TAB, CORYPHEN 650 CODEINE 30 TAB | No marketed DIN |
| WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC. | 2 | 0 | C2 BUFFERED WITH CODEINE TAB, C2 TAB WITH CODEINE | No marketed DIN |
| CANAPHARM MANUFACTURING INC | 1 | 0 | ASA, CAFFEINE & 8MG CODEINE PHOSPHATE | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 1 | 0 | ACETYLSALICYLIC ACID, CAFFEINE AND 8 MG CODEINE PHOSPHATE | No marketed DIN |
| VITA HEALTH PRODUCTS INC | 1 | 0 | AC&C TABLETS | No marketed DIN |
| WESTCAN PHARMACEUTICALS LTD. | 1 | 0 | A.C. & C. 8MG | No marketed DIN |
| WHITEHALL-ROBINS INC. | 1 | 0 | ANACIN WITH CODEINE TAB | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 30 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Codeine And Acetylsalicylic Acid |
|---|---|
| ATC code | N02AJ07 |
| AHFS class | 52:04.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00219843 |
|---|---|
| DIN (unpadded, as printed on some documents) | 219843 |
| Brand name | 292 TAB |
| Generic / active ingredient | CODEINE PHOSPHATE : 30 MG CAFFEINE CITRATE : 30 MG ACETYLSALICYLIC ACID : 375 MG |
| Market authorization holder | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. |
| Health Canada schedule | NARCOTICS (CDSA I) |
| ATC code | N02AJ07 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02AJ |
| Current status | CANCELLED POST MARKET |
| Status date | 14-Aug-1998 |
| Original market date | 1958-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Codeine And Acetylsalicylic Acid in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by PURDUE PHARMA, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 26 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| 222 TABLETS | 8 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | 00108162 |
| 282 TAB | 15 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | 00108103 |
| 282 TABLETS | 15 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | 02234510 |
| 292 TABLETS | 15 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | 02238645 |
| A & C TABLETS WITH CODEINE 15MG | 15 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | 00095508 |
| A & C TABLETS WITH CODEINE 30MG | 30 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | 00095516 |
| A.C. & C. 8 MG | 8 MG | TABLET | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | 02245670 |
| A.C. & C. 8MG | 15 MG | TABLET | WESTCAN PHARMACEUTICALS LTD. | CANCELLED PRE MARKET | 02230426 |
| A.C.& C TABLETS | 325 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 01922246 |
| AC AND C TAB 1/8GR | 30 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 00589470 |
2 · Same class — other molecules in ATC N02AJ
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Codeine And Paracetamol | (EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS · ACET 2 · ACET 3 · ACET CODEINE 30 · +60 more | 66 | 9 | Yes |
| Tramadol And Paracetamol | ACT TRAMADOL/ACET · AG-ACET-TRAMADOL · APO-TRAMADOL/ACET · AURO-TRAMADOL/ACETAMINOPHEN · +20 more | 24 | 8 | Yes |
| Oxycodone And Paracetamol | APO-OXYCODONE/ACET · ENDOCET · NTP-OXYCODONE ACETAMINOPHEN · NU-OXYCODONE/ACET · +10 more | 14 | 3 | Yes |
| Oxycodone And Acetylsalicylic Acid | ENDODAN · PERCODAN · PERCODAN-DEMI · RIVACODAN · +1 more | 5 | 1 | Yes |
| Codeine And Acetylsalicylic Acid | 222 TABLETS · 282 TAB · 282 TABLETS · 292 TAB · +21 more | 26 | 0 | Not in Canada |
| Hydrocodone And Ibuprofen | CODOFEN · IBUCODONE | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N02AA | Codein, Combinations With Psycholeptics · Codeine, Combinations Excl. Psycholeptics · Hydromorphone · Morphine · Natural Opium Alkaloids · +3 more | 378 | 129 |
| N02AX | Tapentadol · Tramadol | 41 | 30 |
| N02AB | Fentanyl · Pethidine | 105 | 17 |
| N02AE | Buprenorphine | 15 | 4 |
| N02AF | Butorphanol · Nalbufine | 5 | 2 |
| N02AC | Dextropropoxyphene · Dextropropoxyphene, Comb Excl Psycholept | 7 | 0 |
| N02AD | Pentazocine | 3 | 0 |
| N02AG | Opioids In Comb With Antispasmodics | 3 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is 292 TAB called?
The same molecule, Codeine And Acetylsalicylic Acid, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Brunacod | Latin | South Africa |
| Ibupain Forte | Latin | South Africa |
| Spectrapain | Latin | South Africa |
| Codef Cough | Latin | South Africa |
| Docsed | Latin | South Africa |
| Lenazine Forte | Latin | South Africa |
| Mybucod | Latin | South Africa |
| Suncodin Tablets | Latin | South Africa |
| ACTIFED COMPOUND LINCTUS | Latin | Saudi Arabia |
| Adco-Kiddipayne | Latin | South Africa |
| Adco-Metaxol | Latin | South Africa |
| AstraPain Syrup | Latin | South Africa |
| Ban Pain A/F | Latin | South Africa |
| Codeine | Latin | South Africa |
| CODETUX AD | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.